Molecular Partners completes IPO

Molecular Partners AG (SIX:MOLN), Schlieren, Switzerland Business: Ophthalmic, Cancer, Inflammation Date completed: 2014-11-04 Type: IPO Raised: CHF96.5 million ($100 million) Shares: 4.4 million Pric...